Kyverna Therapeutics
KYTX
#7728
Rank
A$0.53 B
Marketcap
A$12.26
Share price
0.00%
Change (1 day)
70.27%
Change (1 year)

Kyverna Therapeutics (KYTX) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : A$63.13 Million

According to Kyverna Therapeutics's latest financial reports the company's total liabilities are A$63.13 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Kyverna Therapeutics - Total liabilities on balance sheet (from 2022 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$61.18 M-79.82%
2023-12-31A$0.30 B46.43%
2022-12-31A$0.20 B13.96%
2021-12-31A$0.18 B